Compare RNGR & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNGR | ORGO |
|---|---|---|
| Founded | 2017 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 403.7M | 348.6M |
| IPO Year | 2017 | 2016 |
| Metric | RNGR | ORGO |
|---|---|---|
| Price | $16.28 | $2.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $20.00 | $8.50 |
| AVG Volume (30 Days) | 282.0K | ★ 1.3M |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.81% | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ 0.12 | N/A |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | $23.86 | N/A |
| Revenue Next Year | $4.37 | $26.27 |
| P/E Ratio | $136.00 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $10.56 | $2.04 |
| 52 Week High | $18.82 | $7.08 |
| Indicator | RNGR | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 56.61 |
| Support Level | $15.62 | $2.21 |
| Resistance Level | $17.94 | $4.12 |
| Average True Range (ATR) | 0.52 | 0.18 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 36.80 | 83.89 |
Ranger Energy Services Inc offers high specification mobile rig well services, cased hole wireline services, and ancillary services in the U.S. oil and gas industry. Its services facilitate operations throughout the lifecycle of a well, including the completion, production, maintenance, intervention, workover, and abandonment phases. The company's reportable segments are: High Specification Rigs, Wireline Services, Processing Solutions and Ancillary Services. Maximum revenue is generated from the High Specification Rigs segment, which offers high specification well service rigs and complementary equipment and services to facilitate operations throughout the lifecycle of a well. The high specification rig services consist of well completion support, workovers, and well maintenance services.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.